A nationwide shortage of the asthma medication albuterol has been ongoing since last fall and experts fear it's only expected to get worse. Albuterol can be taken in several forms but it's the ...

Several major manufacturing plants for the asthma and respiratory drug Albuterol have shut down, possibly worsening an already-flaring shortage of the medication that has forced hospitals to devise ...

In Teva Branded Pharm. Prods. R&D v. Amneal Pharms. of N.Y., LLC, the US District Court for the District of New Jersey ordered Teva to delist five patents from the Food and Drug Administration (FDA)’s ...

LAKE FOREST, Ill. -- An ongoing shortage of a medicine commonly used to treat people with breathing problems is expected to get worse after a major supplier to US hospitals shut down last week, CNN ...

When it comes to questioning drug patents, the U.S. Federal Trade Commission (FTC) isn’t backing down. After filing a challenge in November against more than 100 patents in the FDA’s Orange Book—and ...

Please provide your email address to receive an email when new articles are posted on . Since 2004, students with asthma have had the right to self-carry and self-administer their quick-relief ...

Credit: Getty Images. The recall affects products manufactured in November 2021. Cipla has initiated a recall of 6 batches of Albuterol Sulfate Inhalation Aerosol, 90mcg (200 metered inhalation) due ...

Randomized trial compares valved holding chambers for albuterol inhalation therapy ...

Credit: AstraZeneca. Airsupra combines albuterol, a short-acting beta2-agonist, and budesonide, an inhaled corticosteroid. Airsupra ® (albuterol/budesonide) is now available for the as-needed ...